Preclinical scientific tests suggest that retatrutide might affect weight problems-affiliated most cancers development. Within a research led by Marathe et al., retatrutide-induced weight reduction lowered tumor engraftment, delayed tumor onset, and noticeably attenuated tumor expansion in pancreati